Psychiatry & Neurology Doctors in Ardmore, OK Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Aaron Tabor, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1011 14th Ave Nw, Ardmore, OK 73401 Phone: 580-262-4737

Craig Steven Tutton, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1212 Merrick Drive, Ardmore, OK 73401 Phone: 580-224-0331    Fax: 580-224-0334

Jahannah H Jamelarin, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1104 Walnut Dr, Ardmore, OK 73401 Phone: 580-226-0543    Fax: 580-226-2284

Baha Al-deen Abu-esheh, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 908 N Rockford Rd Ste A, Ardmore, OK 73401 Phone: 580-223-0447    Fax: 580-223-2989

Dr. Ann Marie Baker, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2530 S Commerce St, Ardmore, OK 73401 Phone: 580-223-5636

News Archive

Aradigm commences patient dosage in Phase 2 trial of novel inhaled ciprofloxacin formulation

Aradigm Corporation today announced that the first patient was dosed in a 6-month, multicenter, international Phase 2 clinical trial of a novel version of inhaled ciprofloxacin (ARD-3150) in 40 adult patients with non-cystic fibrosis bronchiectasis.

ASPREE trial explores whether low dose aspirin can prolong good health in elderly people

The ASPREE trial of more than 19,000 participants in Australia and the US is the largest and most comprehensive study to look at whether the many millions of older people around the world who take (100mg) low dose aspirin to preserve good health are deriving any benefit by doing so.

TRITON-TIMI 38 study evaluates response rates in patients with common genetic variant in ABCB1 gene

A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the ABCB1 gene. Patients enrolled in the TRITON-TIMI 38 study were treated with dual antiplatelet therapy with either Plavix® (clopidogrel) plus aspirin or Effient® (prasugrel) plus aspirin and managed with percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS) event.

DSS VistA Chemotherapy Manager goes live at San Francisco VA Medical Center

DSS, Inc., a leading provider of software development, integration, project management, implementation and support of VistA, today announced that its customized VistA Chemotherapy Manager (VCM) system is now live and in production at the San Francisco VA Medical Center.

OncoGenex Pharmaceuticals president named Canada's Pacific Ernst & Young's Entrepreneur Of The Year

OncoGenex Pharmaceuticals, Inc., announced today that Scott Cormack, president and chief executive officer of OncoGenex, has been named Canada's Pacific Ernst & Young's Entrepreneur Of The Year(R). The Ernst & Young Entrepreneur Of The Year(R) Award is a high profile business award recognizing entrepreneurs that are building successful, dynamic businesses.

Read more Medical News

› Verified 9 days ago